US Stocks

Immuneering Corporation

Immuneering Corporation, located in Cambridge, Massachusetts, specializes in developing oncology and neuroscience product candidates for the treatment of cancer and solid tumors. Its lead product candidates include IMM-1-104 and IMM-6-415, and the company has five oncology programs in the discovery stage and two neuroscience programs. Founded in 2008, Immuneering Corporation was previously a subsidiary of Teva Pharmaceutical Industries Limited.